Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)
NARecruitingINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
December 14, 2017
Primary Completion Date
December 14, 2027
Study Completion Date
December 14, 2034
Conditions
Mayer Rokitansky Kuster Hauser Syndrome
Interventions
PROCEDURE
Uterine transplantation
Uterine transplantation from living donor
Trial Locations (1)
92150
RECRUITING
Hopital Foch, Suresnes
All Listed Sponsors
lead
Hopital Foch
OTHER
NCT03689842 - Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH) | Biotech Hunter | Biotech Hunter